Skip to main content
Log in

On the role of the peroxisome in cell differentiation and carcinogenesis

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

This article reviews the currently available data on the role of peroxisomal function in relation to the processes of cell differentiation and carcinogenesis. In regard to tumourigenesis, both genotoxic and non-genotoxic processes have been considered, and the peroxisomal relationships with these phenomena and with differentiation are described at the level of organelle characteristics, enzyme contents, and the involvement of retinoids, steroid hormones, oxygen free radicals, growth factors, apoptosis, omega-3 polyunsaturated fatty acids and the cellular signalling networks. Overall these data serve to illustrate the unique and distinctive role of the peroxisome in differentiation and carcinogenesis, and point to the advantages of considering the peroxisomal involvement in the holistic context of the differentiation dedifferentiation continuum rather than the narrower focus of non-genotoxic carcinogenesis. The review also outlines the potential for medical benefit arising from a fuller understanding of these peroxisomal affiliations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Harris CC: Chemical and physical carcinogenesis: Advances and perspectives for the 1990's. Cancer Res 51(Suppl): 5023S-5044S, 1991

    Google Scholar 

  2. Ames BN, Gold LS, Willett WC: The causes and prevention of cancer. Proc Natl Acad Sci 92: 5258-5265, 1995

    Google Scholar 

  3. Masters CJ, Holmes RS: Haemoglobin, isoenzymes and tissue differentiation, North Holland. Frontiers of Biology Series, Amsterdam, 1975

  4. Reddy JK, Azarnoff DL, Highnite CE: Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397-398, 1980

    Google Scholar 

  5. Masters CJ, Crane DI: On the role of the peroxisome in ontogeny, ageing and degenerative disease. Mech Ageing Devel 80: 69-83, 1995

    Google Scholar 

  6. Lake BG: Peroxisome proliferation: Current mechanisms relating to nongenotoxic carcinogenesis. Toxicol Lett 82-3: 673-681, 1995

    Google Scholar 

  7. Masters C, Crane D: The Peroxisome - A Vital Organelle. Cambridge University Press, Cambridge, 1995

    Google Scholar 

  8. de Duve C: Microbodies in the living cell. Sci Am 248: 52-62, 1983

    Google Scholar 

  9. van den Bosch H, Schutgens RBH, Wanders RJA, Tager JM: Biochemistry of peroxisomes. Ann Rev Biochem 61: 157-197, 1992

    Google Scholar 

  10. Roels F: Peroxisomes. VUB Press, Brussels, 1991

    Google Scholar 

  11. Moser HW: In: H. Harris, K. Hirschhorn (eds). Peroxisomal Disorders and Advances in Human Genetics. Vol. 21. Plenum, New York, 1993, pp 1-106

    Google Scholar 

  12. Masters C, Holmes R: Peroxisomes, new aspects of cell physiology and biochemistry. Physiol Rev 57: 816-882, 1977

    Google Scholar 

  13. Keller JM, Cable S, Elbouhtory F, Heusser S, Scotto C, Armbruster L, Ciolek E, Colin S, Schilt J: Peroxisomes through cell differentiation and neoplasia. Biol Cell 77: 77-88, 1993

    Google Scholar 

  14. Peterson SL, Stevenson PM: Changes in catalase activity and concentration during ovarian development and differentiation. Biochem Biophys Acta 1135: 207-214, 1992

    Google Scholar 

  15. Van den Branden C, Dacremont G, Hoogh R, Roels F: Inhibition of peroxisomal β-oxidation and brain development in rats. Glia 2: 260-265, 1989

    Google Scholar 

  16. Lazo O, Singh AK, Singh I: Postnatal development and isolation of peroxisomes from brain. J Neurochem 56: 1343-1353, 1991

    Google Scholar 

  17. Mangelsdorf DJ, Kliewer SA, Kakizuke A, Umesono K, Evans RM: Retinoid receptors. Recent Prog Horm Res 48: 99-121, 1993

    Google Scholar 

  18. Beier K, Volkl A, Fahimi HD: The impact of aging on enzyme proteins of rat liver peroxisomes: Quantitative analysis by immunoblotting and immunoelectron microscopy. Virchows Arch B Cell Pathol 63: 139-146, 1993

    Google Scholar 

  19. Perichon R, Bourre JM: Liver peroxisomal fatty acid oxidizing system during aging in control and clofibrate-treated mice. Biochem Mol Biol Int 37: 475-480, 1995

    Google Scholar 

  20. Greenstein JP, Jenrette WV, White J: The liver catalase activity of tumour-bearing rats and the effect of extirpation of the tumours. J Natl Cancer Inst 2: 283-291, 1941

    Google Scholar 

  21. Greenstein JP: Biochemistry of Cancer. Academic Press, New York, 1947, pp 325-330

    Google Scholar 

  22. Nishimura ET, Kobara TY, Kaltenbach JP, Wartman WB: Immunological evidence of repressed catalase synthesis in livers of tumour-bearing mice. Arch Biochem Biophys 97: 589-595, 1962

    Google Scholar 

  23. Rabilloud T, Asselineau D, Miguel C, Calvayrac R, Darmon M, Vuillaume M: Deficiency in catalase activity correlates with the appearance of tumour phenotype in human keratinocytes. Int J Cancer 45: 952-956, 1990

    Google Scholar 

  24. Kampschmidt RF: Mechanism of liver catalase depression in tumourbearing animals: A review. Cancer Res 25: 34-45, 1964

    Google Scholar 

  25. Green S: Receptor mediated mechanisms of peroxisome proliferators. Biochem Pharmacol 43: 393-401, 1992

    Google Scholar 

  26. Green S, Tugwood JD, Isseman I: The molecular mechanism of peroxisome proliferator action: A model for species differences and mechanistic risk assessment. Toxicol Lett 131-9: 64-65, 1992

    Google Scholar 

  27. Masters C, Crane D: Recent developments in peroxisome biology. Endeavour 20: 68-73, 1996

    Google Scholar 

  28. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W: Control of the peroxisomal β oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887, 1992

    Google Scholar 

  29. Desvergme B, Wahli W: PPAR: A key nuclear factor in nutrient/gene interactions. In: P. Baeurle (ed). Progress in Gene Expression. Vol. 1. Birkhaüser, Boston, 1994, pp 142-176

    Google Scholar 

  30. Kliewer SA, Forman BM, Ong ES, Borgmeyer V, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359, 1994

    Google Scholar 

  31. Bojes HK, Thurman RG: Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo. Toxicol Appl Pharmacol 126: 233-239, 1994

    Google Scholar 

  32. Wahli W, Braissant O, Desvergne B: Peroxisome proliferator activated receptors: Transcriptional regulators of adipogenesis, lipid metabolism and more... Chemistry and Biology 2: 261-266, 1995

    Google Scholar 

  33. Evans RM: The steroid and thyroid hormones receptor superfamily science 240: 889-895, 1988

    Google Scholar 

  34. Van Poppel G: Carotenoids and cancer: An update with emphasis on human intervention studies. Eur J Cancer 29A: 1335-1344, 1993

    Google Scholar 

  35. Moon MK, Mehta M: Chemoprevention of mammary cancer by retinoids. Basic Life Sci 52: 213-224, 1990

    Google Scholar 

  36. Chawla A, Lazar MA: Peroxisome proliferator and retinoid signaling pathways coregulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA 91: 1786-1790, 1994

    Google Scholar 

  37. Stunnenberg HG: Mechanisms of transactivation by retinoic acid receptors. Bioessays 15: 309-315, 1993

    Google Scholar 

  38. Sher T, Yi H-F, McBride OW, Gonzalez FJ: CDNA cloning chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32: 5598-5604, 1993

    Google Scholar 

  39. Crane DI, Masters CJ: Alterations in the integrity of peroxisomal membranes in livers of mice treated with peroxisome proliferators. Mol Cell Biochem 96: 153-161, 1990

    Google Scholar 

  40. Vineis P, Brandt-Rauf PW: Mechanisms of carcinogenesis: Chemical exposure and molecular changes. Eur J Biochem 29A: 1344-1347, 1993

    Google Scholar 

  41. Miyashita T, Reed JC: Tumour suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995

    Google Scholar 

  42. Hunter T: Braking the cycle cell 75: 839-841, 1993

    Google Scholar 

  43. Rao MS, Yeldandi AV, Subbarao V, Reddy JK: Evidence that ciprofibrate, a potent peroxisome proliferator is a complete carcinogen in the rat. Proc Am Assoc Cancer Res 31: 86, 1990

    Google Scholar 

  44. Rao MS, Reddy JK: An overview of peroxisome proliferator-induced hepatocarcinogenesis. Environ Health Perspect 93: 205-209, 1991

    Google Scholar 

  45. Yokoyama Y, Tsuchida S, Hatayama I, Sato K: Lack of peroxisomal enzyme inducibility in rat hepatic preeoplastic lesions induced by mutagenic carcinogens: Contrasted expression of glutathione Stransferase P form and enoyl CoA hydratase carcinogenesis 14: 393-398, 1993

    Google Scholar 

  46. Dhaunsi GS, Singh I, Orak JK, Singh AK: Antioxidant enzymes in ciprofibrate-induced oxidative stress. Carcinogenesis 15: 1923-1930, 1994

    Google Scholar 

  47. Orellana A, Holoigue L, Hidalgo PC, Faundez V, Gonzalez A, Bronfman M: Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal growth factor receptor in isolated rat hepatocytes. Eur J Biochem 215: 903-906, 1993

    Google Scholar 

  48. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants and the degenerative diseases of ageing. Proc Natl Acad Sci USA 90: 7915-7922, 1993

    Google Scholar 

  49. Moody DE, Reddy JK, Lake BG, Popp JA, Reese DH: Peroxisome proliferation and non-genotoxic carcinogenesis - commentary on a symposium. Fund Appl Toxicol 16(2): 233-248, 1991

    Google Scholar 

  50. Clayson DB, Mehta R, Iverson F: Oxidative DNA damage - the effects of certain genotoxic and operationally non-genotoxic carcinogens. Mutat Res 317: 25-42, 1994

    Google Scholar 

  51. Rao MS, Lalwani ND, Watanabe TK, Reddy JK: Inhibitory effects of anitoxidants ethoxyquin and 2(3)-tert-buty-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res 44: 1072-1076, 1984

    Google Scholar 

  52. Chance B, Sies H, Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605, 1979

    Google Scholar 

  53. Janssen YMW, Houten B, Borm PJA, Mossmann BT: Cell and tissue responses to oxidative damage. Lab Invest 69: 261-271, 1993

    Google Scholar 

  54. Sun Y: Free radicals, antioxidant enzymens and carcinogenesis. Free Rad Biol Med 8: 583-599, 1990

    Google Scholar 

  55. Takagi A, Sai K, Umemura T, Hasegawa R, Kurokawa Y: Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyquanosine formation in liver DNA of rats following long term exposure to three peroxisome proliferators. Cancer Lett 53: 33-38, 1990

    Google Scholar 

  56. Cattley RC, Glover SE: Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: Relationship to carcinogenesis and nuclear localisation carcinogenesis 14: 2495-2499, 1993

    Google Scholar 

  57. Ames BN, Gold LS: Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 249: 970-971, 1990

    Google Scholar 

  58. Grisham JW, Kaufman WK, Kaufman DG: The cell cycle and carcinogenesis. Surv Synth Pathol Res 1: 49-66, 1983

    Google Scholar 

  59. Lehninger AL, Nelson DL, Cox MM: Principles of Biochemistry, 2nd edn. Worth Publishers, New York, 1992

    Google Scholar 

  60. Hegi ME, Fox TR, Belinsky SA, Devereux TR, Anderson MA: Analysis of activated protooncogenes in B6C3F1 mouse liver tumours induced by ciprofibrate, a potent peroxisome proliferator. Carcinogenesis 14: 145-149, 1993

    Google Scholar 

  61. Hamilton GA: Oxalyl thiolesters, novel intermediates in biological systems. In: V.T. D'Souza, T. Feder (eds). The Bioorganic Chemistry of Enzymatic Analysis: An Homage to Myron L. Bender, CRC Press, Ann Arbor, 1991, pp 79-89

    Google Scholar 

  62. Hamilton GA: Peroxisomal oxidases and suggestions for the mechanism of action of insulin and other hormones. Adv Enzymol 57: 85-178, 1985

    Google Scholar 

  63. Masters C: Cellular signalling: The role of the peroxisome Cell. Signalling 8: 197-208, 1996

    Google Scholar 

  64. Borek C: ω-3 Fatty acids as an anticarcinogens: Cellular and molecular studies. In: C. Galli, A.P. Simopoulos, E. Tremoli (eds). Effects of Fatty Acids and Lipids in Health and Disease. Vol. 76, Karger, Basel, 1994, pp 66-69

    Google Scholar 

  65. Masters C: Omega-3 fatty acids and the peroxisome. Mol Cell Biochem 165: 83-93, 1996

    Google Scholar 

  66. Lake BG: Mechanisms of hepatocarcinogenility of peroxisome proliferating drugs and chemicals. Ann Rev Pharmacol Toxicol 35: 483-507, 1995

    Google Scholar 

  67. Bayly AL, Roberts RA, Dive C: Suppression of liver cell apoptosis in vitro by the nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin. Cell Biol 125: 197-203, 1994

    Google Scholar 

  68. Bayly AC, French NJ, Dive C, Roberts RA: Non genotoxic hepatocarcinogenesis in vitro: The FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis. J Cell Sci 104: 307-315, 1993

    Google Scholar 

  69. Kashiwagi A: Peroxisomal enzyme activity changes in the tail of Anuran tadpoles during metamorphosis. Comp Biochem Physiol B Biochem Mol Biol III: 483-489, 1995

  70. Claria J, Serhan EN: Aspirin triggers previously underscribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92: 9475-9482, 1995

    Google Scholar 

  71. Masters C: On the role of the peroxisome in the metabolism of drugs and xenobiotics. Biochem Pharmacol (in press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Masters, C., Crane, D. On the role of the peroxisome in cell differentiation and carcinogenesis. Mol Cell Biochem 187, 85–97 (1998). https://doi.org/10.1023/A:1006863123068

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006863123068

Navigation